Are you at least 21 years old?
You must be at least 21 to see this content, you will be redirected to google
Are you at least 21 years old?
You must be at least 21 to see this content, you will be redirected to google
A
• amyotrophic-lateral-sclerosis-als-lou-gehrigs (2)
• attention-deficit-hyperactivity-disorder-adhd (5)
B
C
D
• d9-tetrahydrocannabinol-thc (4)
• d9-tetrahydrocannabinolic-acid-thca (1)
E
• endocannabinoid-system-ecs (45)
F
G
• gastrointestinal-disease (6)
H
I
K
L
M
N
• national-institute-on-drug-abuse-nida (1)
• neuro-protective-and-neuro-generative (7)
P
S
T
• traumatic-brain-injury-tbi (1)
• View All (505)The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease (2014)
In this study, we summarize the role of endocannabinoid signaling in Alzeimer disease and the probable mechanisms through which modulators of the endocannabinoid system provide their effects, thus highlighting how this objective could provide more advantages than other therapeutic objectives. View study
The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's disease. (2017)
Alzheimer’s disease (AD) is the most common neurodegenerative disorder, characterized by a progressive loss of cognition. The present review was focused on presenting a brief introduction to (AD) biology and current treatment options before outlining comprehensively phytocannabinoid cannabidiol (CBD) biology and pharmacology, followed by in-vitro and in-vivo evidence for the therapeutic potential of (CBD). View study